Net Income Endring Dato
Acadia Pharmaceuticals USD 45.8M 110.97M 2023-12
Agios Pharmaceuticals USD -95940000 4.62M 2023-12
Alnylam Pharmaceuticals USD -137870000 285.62M 2023-12
Amgen USD 767M 963M 2023-12
Bayer EUR -4569000000 2.68B 2023-09
Biogen USD 249.7M 317.8M 2023-12
BioMarin Pharmaceutical USD 20.38M 20M 2023-12
Bluebird Bio USD -71731000 1.18M 2023-09
Gilead Sciences USD 1.43B 751M 2023-12
Incyte USD 201.08M 29.81M 2023-12
Insmed USD -186061000 27.13M 2023-12
Ionis Pharmaceuticals USD -9263000 138.15M 2023-12
Moderna USD 217M 3.85B 2023-12
Neurocrine Biosciences USD 83.1M 12.4M 2023-09
PTC Therapeutics USD -155792000 22.82M 2023-12
Regeneron Pharmaceuticals USD 1.16B 151.8M 2023-12
Roche Holding CHF 7.14B 3.25B 2023-06
Sarepta Therapeutics USD -40937000 17M 2023-09
Ultragenyx Pharmaceutical USD -123190000 36.46M 2023-12
United Therapeutics USD 217.1M 50.5M 2023-12
Vertex Pharmaceuticals USD 1.04B 119.6M 2023-09



BioMarin Pharmaceutical Netto Inntekt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.